MITA releases dose-related standard

Editorial Staff | | Health Imaging | Practice Management

The Medical Imaging & Technology Alliance (MITA) has released the XR-29 Standard Attributes on CT Equipment Related to Dose Optimization and Management, also known as MITA Smart Dose.

MITA Smart Dose is a standard that includes four key features of CT equipment that enable optimization or management of radiation dose delivery while maintaining high image quality, according to a release from MITA. The four features identified by MITA are:

  • DICOM Dose Structured Reporting—Structured reporting enables recording of post-exam dose information in a standardized electronic format. The information can be included in the patient record, promoting the establishment of diagnostic reference levels, as well as facility dose management and quality assurance.
  • CT Dose Check—Dose notifications and dose alerts warn operators and physicians when dose exceeds stable thresholds.
  • Automatic Exposure Controls—Automated technology can adjust the amount of radiation within prescribed bounds as needed to achieve the desired image quality.
  • Pediatric and adult reference protocols—Pre-loaded parameters on a CT system that can be selected by the operator to complete a particular clinical task, such as capturing an image of the abdomen. 

The XR-29 standard is the fourth dose-related standard to be released by MITA since 2010.

Editorial Staff

Related Content

Policies and regulations shaping radiology in 2025
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
Bracco's latest move marks a step toward improving sustainability in radiology
New protocol addresses contrast allergies in patients with suspected stroke
Do large language models help or hinder workflows related to radiology reports?

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.